Product
Supplier
Encyclopedia
Inquiry
Home > Chemicals Market Price & Insight > Ofloxacin Market Price & Analysis > Featured News - Ofloxacin > Zhengzhou People's Pharmaceutical has a total investment of 130 million yuan in the rifamycin bio-fermentation series product project settled in Kailu
— Share —

Zhengzhou People's Pharmaceutical has a total investment of 130 million yuan in the rifamycin bio-fermentation series product project settled in Kailu

healthoo 2021-10-19
On October 15, the signing ceremony for the rifamycin bio-fermentation series product project between Kailu County and Zhengzhou Minsheng Pharmaceutical Co., Ltd.

Please sign in to view all content or subscribe.

Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.